D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 80 Citations 27,281 221 World Ranking 9748 National Ranking 5294

Research.com Recognitions

Awards & Achievements

1933 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Surgery

His scientific interests lie mostly in Surgery, Ovarian cancer, Internal medicine, Chemotherapy and Oncology. His Surgery research includes themes of Carcinoma and Urology. His Ovarian cancer study combines topics from a wide range of disciplines, such as Stage, Gynecologic oncology, Gynecology and Disease.

His work on Cancer, Breast cancer and Proportional hazards model is typically connected to Population as part of general Internal medicine study, connecting several disciplines of science. His Chemotherapy study integrates concerns from other disciplines, such as Clinical trial and Ovary. William J. Hoskins has included themes like Radical Hysterectomy and Cervix in his Oncology study.

His most cited work include:

  • Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer (2442 citations)
  • Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer (2442 citations)
  • Impact of hospital volume on operative mortality for major cancer surgery. (1357 citations)

What are the main themes of his work throughout his whole career to date?

William J. Hoskins mostly deals with Surgery, Internal medicine, Ovarian cancer, Oncology and Chemotherapy. His biological study spans a wide range of topics, including Carcinoma and Urology. In general Internal medicine, his work in Cancer, Ovary and Ovarian carcinoma is often linked to In patient linking many areas of study.

His Ovarian cancer study combines topics in areas such as Gynecologic oncology, Disease, Pathology, Gynecology and General surgery. William J. Hoskins has researched Oncology in several fields, including Cyclophosphamide, Paclitaxel and Epithelial ovarian cancer. His work deals with themes such as Regimen and Clinical trial, which intersect with Chemotherapy.

He most often published in these fields:

  • Surgery (40.97%)
  • Internal medicine (40.97%)
  • Ovarian cancer (39.24%)

What were the highlights of his more recent work (between 2000-2015)?

  • Internal medicine (40.97%)
  • Ovarian cancer (39.24%)
  • Oncology (31.60%)

In recent papers he was focusing on the following fields of study:

William J. Hoskins focuses on Internal medicine, Ovarian cancer, Oncology, Surgery and Gynecology. His Ovarian cancer research is multidisciplinary, incorporating perspectives in Retrospective cohort study, Paclitaxel, Chemotherapy and Proportional hazards model. Within one scientific family, he focuses on topics pertaining to Progression-free survival under Oncology, and may sometimes address concerns connected to Cyclophosphamide.

His Surgery research incorporates elements of Disease and General surgery. The Gynecology study combines topics in areas such as Gynecologic oncology, Clinical trial, Endometrial cancer and Family medicine. His Stage research is multidisciplinary, incorporating elements of Gastroenterology, Combination chemotherapy and Cisplatin.

Between 2000 and 2015, his most popular works were:

  • Identification of prognostic factors in advanced epithelial ovarian carcinoma. (200 citations)
  • Diagnosis and Management of Epithelial Ovarian Cancer (166 citations)
  • Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review (146 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Surgery

His primary areas of study are Surgery, Ovarian carcinoma, Ovarian cancer, Gynecology and Internal medicine. His study in the fields of Proportional hazards model, Robotic surgery and Laparotomy under the domain of Surgery overlaps with other disciplines such as Indirect costs. The study incorporates disciplines such as Neoadjuvant therapy and Chemotherapy in addition to Ovarian cancer.

His study in Chemotherapy is interdisciplinary in nature, drawing from both Randomized controlled trial and Clinical trial. His studies deal with areas such as Stage, Gastroenterology and Endometrial cancer as well as Gynecology. William J. Hoskins works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Carcinoma.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire;William J. Hoskins;Mark F. Brady;Paul R. Kucera.
The New England Journal of Medicine (1996)

4124 Citations

Impact of hospital volume on operative mortality for major cancer surgery.

Colin B. Begg;Laura D. Cramer;William J. Hoskins;Murray F. Brennan.
JAMA (1998)

2108 Citations

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer

David S. Alberts;P. Y. Liu;Edward V. Hannigan;Robert O'Toole.
The New England Journal of Medicine (1996)

1596 Citations

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

M Markman;R Rothman;T Hakes;B Reichman.
Journal of Clinical Oncology (1991)

1040 Citations

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.

William J. Hoskins;William P. McGuire;Mark F. Brady;Howard D. Homesley.
American Journal of Obstetrics and Gynecology (1994)

906 Citations

Symptom prevalence, characteristics and distress in a cancer population

R. K. Portenoy;H. T. Thaler;A. B. Kornblith;J. McCarthy Lepore.
Quality of Life Research (1994)

848 Citations

Ovarian Cancer: Screening, Treatment, and Follow-up

Vicki Seltzer;Bruce H. Drukker;Brenda W. Gillespie;Lynn M. Gossfeld.
JAMA (1995)

802 Citations

The influence of cytoreductive surgery on recurrence-free interval and survival in small volume stage III epithelial ovarian cancer : a Gynecologic Oncology Group study

W J Hoskins;B N Bundy;J T Thigpen;G A Omura.
Gynecologic Oncology (1992)

684 Citations

Clinicopathologic Features of BRCA-Linked and Sporadic Ovarian Cancer

Jeff Boyd;Yukio Sonoda;Mark G. Federici;Faina Bogomolniy.
JAMA (2000)

634 Citations

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.

G. J. S. Rustin;A. E. Nelstrop;P. Mcclean;M. F. Brady.
Journal of Clinical Oncology (1996)

430 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing William J. Hoskins

Dennis S. Chi

Dennis S. Chi

Memorial Sloan Kettering Cancer Center

Publications: 165

Maurie Markman

Maurie Markman

The University of Texas MD Anderson Cancer Center

Publications: 123

Richard R. Barakat

Richard R. Barakat

Northwell Health

Publications: 118

Giovanni Scambia

Giovanni Scambia

Catholic University of the Sacred Heart

Publications: 104

Robert E. Bristow

Robert E. Bristow

University of California, Irvine

Publications: 94

Nadeem R. Abu-Rustum

Nadeem R. Abu-Rustum

Memorial Sloan Kettering Cancer Center

Publications: 94

Yukio Sonoda

Yukio Sonoda

Memorial Sloan Kettering Cancer Center

Publications: 80

Ignace Vergote

Ignace Vergote

KU Leuven

Publications: 78

David M. Gershenson

David M. Gershenson

The University of Texas MD Anderson Cancer Center

Publications: 65

Carol Aghajanian

Carol Aghajanian

Memorial Sloan Kettering Cancer Center

Publications: 63

Claes G. Tropé

Claes G. Tropé

University of Oslo

Publications: 62

Jalid Sehouli

Jalid Sehouli

Charité - University Medicine Berlin

Publications: 61

Anil K. Sood

Anil K. Sood

The University of Texas MD Anderson Cancer Center

Publications: 57

Gabriella Ferrandina

Gabriella Ferrandina

Catholic University of the Sacred Heart

Publications: 55

Douglas A. Levine

Douglas A. Levine

New York University

Publications: 54

Franco M. Muggia

Franco M. Muggia

New York University

Publications: 52

Trending Scientists

Dongmei Zhao

Dongmei Zhao

McMaster University

Patrick Le Callet

Patrick Le Callet

University of Nantes

José L. Verdegay

José L. Verdegay

University of Granada

Massimo Guidolin

Massimo Guidolin

Bocconi University

Martin Rosentritt

Martin Rosentritt

University of Regensburg

Todd Richmond

Todd Richmond

Roche (Switzerland)

Giovanni Ciriello

Giovanni Ciriello

Ciriello Lab

Akihiro Iwamatsu

Akihiro Iwamatsu

Osaka University

Ana Allende

Ana Allende

Spanish National Research Council

Cornelia Rumpel

Cornelia Rumpel

Université Paris Cité

Randolph Blake

Randolph Blake

Vanderbilt University

Kalevi Korpela

Kalevi Korpela

Tampere University

Gregory J. Meyer

Gregory J. Meyer

University of Toledo

Leda Cosmides

Leda Cosmides

University of California, Santa Barbara

Catherine A. McCarty

Catherine A. McCarty

University of Minnesota

Arthur P. Bochner

Arthur P. Bochner

University of South Florida

Something went wrong. Please try again later.